2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Company type: 
Developer of compound for the treatment of multiple sclerosis.
Company type: 
Developer of high value proteins and oil body based products for personal care, nutrition and pharmaceutical industries.
Company type: 
Specialty pharmaceutical company developing local minimally-invasive drug-device convergence products.
Company type: 
Publicly traded biopharmaceutical company focused on developing and commercializing novel treatments in oncology.
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products